Characteristics affecting oral anticoagulant therapy choice among patients with non-valvular atrial fibrillation: a retrospective claims analysis

Table 2 Pre-index patient demographic, healthcare provider, and health plan characteristics

Characteristics	All patient cohorts					OAC-naïve cohorts
	Dabigatran (n = 3,019)		Warfarin (n = 17,301)		P-value	Dabigatran (n = 815)		Warfarin (n = 1,590)		P-value
	N/mean	%/SD	N/mean	%/SD	P-value	N/mean	%/SD	N/mean	%/SD	P-value
Patient demographic variables
Age (years), n,%
18-44	57	1.9	147	0.8	<.0001	30	3.7	22	1.4	<.0001
45-54	297	9.8	897	5.2		108	13.3	132	8.3
55-64	1,040	34.4	3,299	19.1		313	38.4	363	22.8
65-74	777	25.7	4,213	24.4		191	23.4	375	23.6
75-84	619	20.5	5,969	34.5		124	15.2	486	30.6
85+	229	7.6	2,776	16.0		49	6.0	212	13.3
Age, mean, SD	67	±11.4	73	±11.4	<.0001	65	±11.9	71	±12.1	<.0001
Female	878	29.1	6,775	39.2	<.0001	224	27.5	563	35.4	<.0001
Health plan and healthcare provider variables
Insurance plan, n,%
Preferred provider organization	2,047	67.8	8,522	49.3	<.0001	556	68.2	841	52.9	<.0001
Health maintenance organization	396	13.1	4,136	23.9		108	13.3	308	19.4
Other	576	19.1	4,643	26.8		151	18.5	441	27.7
Health plan region, n,%
Midwest	648	21.5	6,333	36.6	<.0001	185	22.7	714	44.9	<.0001
Northeast	720	23.8	4,257	24.6		175	21.5	300	18.9
West	966	32.0	3,962	22.9		262	32.1	356	22.4
South	685	22.7	2,749	15.9		193	23.7	220	13.8
Physician specialty, n,%
Cardiology	1,541	51.0	5,234	30.3	<.0001	418	51.3	520	32.7	<.0001
Primary care/internal medicine	424	14.1	6,132	35.5		75	9.2	418	26.3
Other	1,054	34.9	5,935	34.2		322	39.5	652	41.0
Patient out of pocket pharmacy costs during the pre-index period	$1,012	$1,585	$952	$1,050	0.0080	$870	±$2,135	$655	±$735	0.0003

ISSN: 1472-6963